Primary Care Clinics in Amarillo, TX Accepting Medicare
126 Primary Care Clinics found. Showing 121 - 126
 Family Wellness Center Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1920 Medi Park Dr Ste 2, Amarillo, TX 79106 Phone: 806-353-2848 Fax: 806-353-2848 |
Amarillo Medical Group Llc General Practice Medicare: Not Enrolled in Medicare Practice Location: 5211 W. 9th Ave, Suite 140, Amarillo, TX 79106 Phone: 806-622-2725 Fax: 806-352-4887 |
Doctors Clinic Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4714 S Western St, Amarillo, TX 79109 Phone: 806-355-8263 Fax: 806-355-8796 |
High Plains Medical Group, Llc General Practice Medicare: Not Enrolled in Medicare Practice Location: 5211 W 9th Ave, Suite 140, Amarillo, TX 79106 Phone: 806-622-2725 Fax: 806-352-4887 |
Advanced Vitality Chiropractic & Wellness Llc Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 3 Medical Dr Ste B, Amarillo, TX 79106 Phone: 806-570-2666 Fax: 682-201-2226 |
Amarillo Family Physicians Clinic, Pa Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1215 S Coulter St, Amarillo, TX 79106 Phone: 806-359-4701 Fax: 806-353-0091 |
News Archive
UCLA researchers identify receptor that plays key role in repairing damage caused by heart conditions
Studies have shown that a simple treatment called lipid emulsion therapy -; fatty acids administered intravenously -; can heal damage to the heart after a heart attack or cardiac arrest. But researchers haven't understood exactly how the treatment works or whether there are more effective ways to repair the heart.
Proper nutrition during multi-day stage races may prevent harmful changes in bone turnover: Study
The recent start of the North American cycling season marks the beginning of a physically demanding time for elite and professional bicycle racers who participate in multi-day stage races. Previous research has found that competitive cyclists have significantly lower bone mineral density than other endurance athletes, making them more susceptible to fractures.
Pharmasset commences PSI-7977 Phase 2a trial for HCV
Pharmasset, Inc. today announces the initiation of a 28-day Phase 2a study with PSI-7977, a chirally pure isomer form of PSI-7851, a nucleotide analog polymerase inhibitor in development for the treatment of chronic hepatitis C (HCV). The trial will evaluate various doses of PSI-7977 in combination with Pegasys (peginterferon alfa 2a) and Copegus (ribavirin) in patients with HCV genotype 1 who have not been treated previously.
AIDS Healthcare Foundation criticizes Etravirine's pricing
AIDS Healthcare Foundation (AHF) has urged Tibotec Pharmaceuticals Ltd., a division of Johnson & Johnson, to reconsider and reduce its steep price for its newest AIDS drug, etravirine (TMC 125), a non-nucleoside reverse transcriptase inhibitor, (NNRTI), which received Food and Drug Administration (FDA) approval on Friday after a fast track or 'priority review' and approval process granted to companies for medications and therapies intended to treat life-threatening illnesses such as AIDS.
Lowell PHO implements MedVentive's technology to manage risk, quality performance
Lowell General Physician-Hospital Organization, a 280-physician integrated delivery system providing outstanding quality care to patients in the Greater Lowell (Massachusetts) area, has implemented MedVentive's award-winning technology platform to manage risk and quality performance. To effectively manage its capitated and incentive-based quality contracts with multiple payers, Lowell PHO sought a comprehensive, flexible technology platform to manage risk, identify improvement opportunities, and proactively outreach to its physicians and patients.
› Verified 4 days ago